Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy
Year: 2009
Type: article
Study design: Observational Study
Authors: Princess U. Ogbogu, Bruce S. Bochner, Joseph H. Butterfield, Gerald J. Gleich, Johannes Huss-Marp, Jean Emmanuel Kahn, Kristin M. Leiferman, Thomas B. Nutman, Florian Pfab, Johannes Ring, Marc E. Rothenberg, Florence Roufosse, Marie-Helene Sajous, Javed Sheikh, Dagmar Simon, Hans-Uwe Simon, Miguel L. Stein, Andrew Wardlaw, Peter F. Weller, Amy D. Klion
Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Johns Hopkins University, Johns Hopkins Medicine, Mayo Clinic, University of Utah, Helmholtz Munich, Technical University of Munich, Centre Hospitalier Universitaire de Lille, Hôpital Foch, Cincinnati Children's Hospital Medical Center, Université Libre de Bruxelles, Erasmus Hospital, Beth Israel Deaconess Medical Center, Harvard University, University Hospital of Bern, University of Bern, University of Leicester
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: National Science Foundation, GlaxoSmithKline, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Johns Hopkins University, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Fonds De La Recherche Scientifique - FNRS, National Institutes of Health, National Institute of Allergy and Infectious Diseases, NHLBI Division of Intramural Research
Awards: G1817693852, G2433219244, G3441057504, G3506483966, Targeting Siglec-8/-F to treat eosinophil and mast cell related disorders, THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB, G555500194, Th2-associated responses and their control in parasitic helminth infections and related disorders, G663223718, G9000007211, G9000288039
OpenAlex ID: W1977436614